TENECTEPLASE AS A NEW MEDICATION IN MANAGING NO-REFLOW
No-reflow has been defined as “inadequate myocardial perfusion through a given segment of coronary circulation without angiographic evidence of a mechanical obstruction”. Important components of the process are thought to include endothelial ischemic injury producing “blebs” of tissue that directl...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University in Nis, Faculty of Medicine
2012-03-01
|
| Series: | Acta Medica Medianae |
| Subjects: | |
| Online Access: | http://publisher.medfak.ni.ac.rs/2012-html/1-broj/Milan%20Zivkovic-Managing%20no-reflow.pdf |